CV vs BFLY vs HTFL Stock Comparison

CapsoVision, Butterfly Network and Heartflow Prices as of Nov 16, 2026 Peers: Industry group
CV CapsoVision, Inc
$6.47 -0.9% 1M +26.4% 1Y
Market cap
$334.51M
P/E
–
Revenue (TTM)
$13.92M
Div. yield
–
Diagnostic Equipment Healthcare
BFLY Butterfly Network, Inc.
$5.71 -21.1% 1M +169.3% 1Y
Market cap
$1.54B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
2 wins
HTFL Heartflow, Inc.
$46.86 -3.0% 1M +67.5% 1Y
Market cap
$4.09B
P/E
–
Revenue (TTM)
$238.66M
Div. yield
–
Diagnostic Equipment Healthcare
6 wins

Head to Head

8 decided of 12

Heartflow leads on 6 of the 12 questions below (Heartflow 6, Butterfly Network 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCVBFLYHTFLLeader
Larger companyMarket capitalisation $334.51M $1.54B $4.09B HTFL
Cheaper on earningsLower P/E, profitable companies only -11.4x -28.8x -51.8x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — — –
Faster revenue growthRevenue growth, trailing twelve months +6.4% +39.4% +47.4% HTFL
More profitableNet margin, trailing twelve months -210.1% -43.6% -33.1% HTFL
Better return on capitalReturn on invested capital — -30.5% -27.5% HTFL
Less leveragedLower net debt / EBITDA — 2.3x 3.4x BFLY
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +26.4% +169.3% +67.5% BFLY
Better 5-year returnAnnualised price return, 5 years — -8.7%/yr — –
Less volatileAnnualised volatility, 1 year 95.6% 112.4% 78.3% HTFL
Higher overall scoreMean of the five percentile scores vs peers 30/100 53/100 57/100 HTFL

Percentile Scorecard

CVBFLYHTFL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCVBFLYHTFL
Valuation 12 #213 of 243 31 #167 of 243 30 #170 of 243
Growth 6 #214 of 228 88 #28 of 228 79 #49 of 228
Profitability 20 #179 of 222 39 #137 of 222 52 #107 of 222
Financial Health 90 #27 of 248 68 #80 of 248 82 #45 of 248
Shareholder Returns 23 #122 of 159 41 #94 of 159 42 #92 of 159
Overall 30 53 57
  • CV ranked among 252 companies in Medical Devices and Diagnostics
  • BFLY ranked among 252 companies in Medical Devices and Diagnostics
  • HTFL ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCVBFLYHTFLSPY
1 month -0.9%-21.1%-3.0% -3.0%
3 months +0.3%-36.7%+11.7% -4.2%
6 months +1.7%+48.7%+82.7% +0.2%
Year to date -39.5%+50.3%+60.8% +8.5%
1 year +26.4%+169.3%+67.5% +10.1%
3 years —+388.0%— +64.1%
3 years, per year —+69.7%— +18.0%
5 years —-36.6%— +58.1%
5 years, per year —-8.7%— +9.6%

Risk

MeasureCVBFLYHTFLSPY
Volatility, 1Y 95.6%112.4%78.3% 13.8%
Downside volatility, 1Y 88.8%93.7%80.6% 14.2%
Beta vs S&P 500, 1Y 0.712.981.91 1.00
Return / volatility, 1Y 0.281.510.86 0.74
Max drawdown, 5Y -67.8%-92.2%-48.7% -25.4%
From 52-week high -55.1%-42.6%-22.6% -5.0%
52-week high $14.42$9.94$60.53 $779.14
52-week low $4.64$1.97$20.49 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCVBFLYHTFL
P/E now vs peer median -10.4xmedian 26.5x -30.2xmedian 26.5x -53.5xmedian 26.5x
P/S now vs peer median 23.2xmedian 2.7x 13.2xmedian 2.7x 17.8xmedian 2.7x
EV/EBITDA now vs peer median -10.3xmedian 18.6x -29.5xmedian 18.6x -54.4xmedian 18.6x
P/FCF now vs peer median -11.0xmedian 25.6x -58.9xmedian 25.6x -75.9xmedian 25.6x
P/B now vs peer median 12.3xmedian 2.5x 8.8xmedian 2.5x 15.1xmedian 2.5x
PEG now vs peer median —median 0.98 -1.00median 0.98 —median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCVBFLYHTFL
Revenue $13.92M $123.25M $238.66M
Gross profit $6.92M $86.60M $195.33M
Operating income -$29.52M -$57.83M -$79.00M
Net income -$29.25M -$53.69M -$79.02M
Free cash flow -$29.28M -$27.55M -$56.07M
R&D $20.27M $39.57M $96.03M
EPS (diluted) $-0.58 $-0.20 $-0.91
Cash & equivalents $21.76M $122.30M $31.65M
Total debt – $2.92M $2.93M
Shares (diluted) 50.57M 266.50M 87.25M
Enterprise value $275.63M $1.01B $3.84B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCVBFLYHTFL
P/E -10.4x -30.2x -53.5x
P/FCF -11.0x -58.9x -75.9x
P/Operating cash flow -11.1x -69.4x -86.9x
P/S 23.2x 13.2x 17.8x
P/B 12.3x 8.8x 15.1x
P/Tangible book 12.3x 9.1x 15.1x
EV/EBITDA -10.3x -29.5x -54.4x
EV/EBIT -10.2x -26.0x -50.7x
EV/Revenue 21.6x 12.2x 16.8x
EV/FCF -10.3x -54.6x -71.4x
EV/Operating cash flow -10.3x -64.3x -81.8x
PEG (3Y EPS CAGR) – -1.00 –

Growth

14 metrics
MetricCVBFLYHTFL
Revenue growth (1Y) 6.4% 39.4% 47.4%
Revenue CAGR (3Y) – 21.7% –
Gross profit growth (1Y) -0.5% 126.4% 59.6%
Gross profit CAGR (3Y) – 30.5% –
Operating income growth (1Y) -30.1% 33.5% -26.7%
Operating income CAGR (3Y) – 26.9% –
Net income growth (1Y) -29.6% 32.8% 37.0%
Net income CAGR (3Y) – 24.2% –
EPS growth (1Y) -18.5% 36.4% 64.5%
EPS CAGR (3Y) – 30.4% –
Operating cash flow growth (1Y) -41.9% 5.8% 14.8%
Operating cash flow CAGR (3Y) – 41.1% –
Free cash flow growth (1Y) -41.7% -0.1% 8.0%
Free cash flow CAGR (3Y) – 38.8% –

Profitability

14 metrics
MetricCVBFLYHTFL
Gross margin 49.7% 70.3% 81.8%
EBITDA margin -210.4% -41.4% -30.8%
Operating margin -212.1% -46.9% -33.1%
Pretax margin -209.9% -43.5% -33.2%
Net margin -210.1% -43.6% -33.1%
FCF margin -210.3% -22.4% -23.5%
Operating cash flow margin -209.7% -19.0% -20.5%
Return on equity -148.0% -28.7% 13.0%
Return on assets -114.0% -18.8% 10.5%
Return on invested capital – -30.5% -27.5%
Return on capital employed -151.1% -26.6% -26.6%
Asset turnover 0.5x 0.4x 0.7x
Cash conversion (OCF / net income) 1.0x 0.4x 0.6x
Stock comp / revenue 14.8% 20.8% 11.4%

Financial Health

11 metrics
MetricCVBFLYHTFL
Debt / assets – 1.0% 0.8%
Debt / equity – 0.0x 0.0x
Net debt / EBITDA – 2.3x 3.4x
Debt / FCF – -0.1x -0.1x
Liabilities / assets 19.5% 36.0% 20.5%
Equity / assets 80.5% 64.0% 79.5%
Interest coverage – -46.8x -4,938x
Current ratio 5.1x 3.6x 4.4x
Quick ratio 4.0x 2.3x 5.7x
Cash ratio 3.6x 1.8x 4.7x
Altman Z-score 21.14 5.44 31.11

Shareholder Returns

7 metrics
MetricCVBFLYHTFL
Dividend yield – – –
Net buyback yield -4.4% -0.5% -0.4%
Shareholder yield -4.4% -0.5% -0.4%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCVBFLYHTFL
EPS, next fiscal year $-0.58FY2026 $-0.06FY2026 $-0.43FY2026
Revenue, next fiscal year $13.82MFY2026 $117.62MFY2026 $263.06MFY2026
Revenue growth, next FY +2.0%FY2026 +20.5%FY2026 +49.4%FY2026
Revenue growth, the year after +47.0% +22.7% +20.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCVBFLYHTFL
Held by institutions 10.2% 58.4% 100.0%
Institutions holding 50 248 193
Change in shares held, QoQ +27.6% +13.9% +133.0%
Institutions buying 36 144 140
Institutions selling 8 59 38
Buyers to sellers 4.50 2.44 3.68

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CVBFLYHTFL
CV 1.00 0.07 0.04
BFLY 0.07 1.00 0.30
HTFL 0.04 0.30 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CV, BFLY and HTFL?

Heartflow (HTFL) is the largest by market capitalisation: CapsoVision (CV) $334.51M, Butterfly Network (BFLY) $1.54B, Heartflow (HTFL) $4.09B.

Which company is growing faster?

Heartflow (HTFL) grew revenue fastest over the trailing twelve months: CapsoVision (CV) +6.4%, Butterfly Network (BFLY) +39.4%, Heartflow (HTFL) +47.4%.

Which company is more profitable?

Heartflow (HTFL) has the highest net margin (CapsoVision (CV) -210.1%, Butterfly Network (BFLY) -43.6%, Heartflow (HTFL) -33.1%). On return on invested capital, Heartflow (HTFL) leads (Butterfly Network (BFLY) -30.5%, Heartflow (HTFL) -27.5%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: CapsoVision (CV) +26.4%, Butterfly Network (BFLY) +169.3%, Heartflow (HTFL) +67.5%. Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Heartflow (HTFL) has been the steadiest (CapsoVision (CV) 95.6%, Butterfly Network (BFLY) 112.4%, Heartflow (HTFL) 78.3%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CV, BFLY and HTFL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Heartflow (HTFL) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.